Wart Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Wart clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting
Phase 1Phase 2

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NeutropeniaInfectionsWarts+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT00967785
Recruiting

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Cryptococcal MeningitisWartsIdiopathic CD4+ Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID)950 enrolled1 locationNCT00867269
Recruiting
Not Applicable

Project HOPEFUL: A PN-RCT With Implementation Science

Quality of LifeMental HealthOlder Adults (50-90 Years)+4 more
University of Florida400 enrolled1 locationNCT07475039
Recruiting
Phase 4

Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir

Common WartFlat WartPlantar Wart+5 more
Riphah International University40 enrolled2 locationsNCT07448844
Recruiting
Phase 3

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Human Papilloma Virus (HPV)WartsCommon Warts+1 more
Verrica Pharmaceuticals Inc.300 enrolled6 locationsNCT07246590
Recruiting
Phase 2

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

HPV-Related CarcinomaHPV InfectionGenital Wart+1 more
Shanghai Bovax Biotechnology Co., Ltd.330 enrolled1 locationNCT06756269
Recruiting
Not Applicable

Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart

Common Warts
Mazandaran University of Medical Sciences60 enrolled1 locationNCT06737406
Recruiting
Not Applicable

Multicenter Real-World Study of Hyperthermia in Warts of Special Population

Warts
First Hospital of China Medical University400 enrolled1 locationNCT06827938
Recruiting
Phase 2

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Human Papilloma VirusWarts
Zagazig University162 enrolled1 locationNCT05291845
Recruiting
Phase 4

Comparison of Effectiveness of Topical Retinoids Versus Liquid Nitrogen in Treatment of Plantar Warts(Viral Infection)

Viral Warts
Khyber Teaching Hospital98 enrolled1 locationNCT07016360
Recruiting
Phase 4

Tirbanibulin for Pediatric Warts

Warts Hand
The Skin Center Dermatology Group10 enrolled1 locationNCT06791525
Recruiting
Not Applicable

Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts

Warts
First Hospital of China Medical University300 enrolled2 locationsNCT06812065
Recruiting
Phase 3

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts

Palmar or Plantar Warts
Assistance Publique - Hôpitaux de Paris146 enrolled1 locationNCT04814446
Recruiting
Phase 4

Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts

Common WartFlat WartPlantar Wart
Labo'Life162 enrolled18 locationsNCT03977753
Recruiting
Phase 3

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Cervical CancerVaginal CancerVulvar Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd.8,000 enrolled1 locationNCT04422366
Recruiting
Phase 3

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Cervical CancerVaginal CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd.1,200 enrolled1 locationNCT04895020
Recruiting
Phase 3

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Vaginal CancerCIN1CIN2+4 more
Shanghai Bovax Biotechnology Co., Ltd.1,348 enrolled1 locationNCT05027776
Recruiting

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Vaginal CancerCIN1CIN2+4 more
Shanghai Bovax Biotechnology Co., Ltd.600 enrolled2 locationsNCT05371353
Recruiting
Phase 2Phase 3

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Warts
Western Institute for Veterans Research120 enrolled2 locationsNCT05625633